Results 221 to 230 of about 144,128 (376)

Proteomic Insight Into Alzheimer's Disease Pathogenesis Pathways

PROTEOMICS, EarlyView.
ABSTRACT Alzheimer's disease (AD) is a leading cause of dementia, but the pathogenesis mechanism is still elusive. Advances in proteomics have uncovered key molecular mechanisms underlying AD, revealing a complex network of dysregulated pathways, including amyloid metabolism, tau pathology, apolipoprotein E (APOE), protein degradation ...
Taekyung Ryu, Kyungdo Kim, Nicholas Asiimwe, Chan Hyun Na   +3 more
wiley   +1 more source

Use of Ionic Liquids in the Enzymatic Synthesis of Structured Docosahexaenoic Acid Lyso-Phospholipids. [PDF]

Molecules
Garcia-Quinto E, Guisan JM, Fernandez-Lorente G.   +2 more
europepmc   +1 more source

PHOSPHOLIPASE A₂ ACTIVITY OF GUINEA‐PIG ISOLATED PERFUSED LUNGS: STIMULATION, AND INHIBITION BY ANTI‐INFLAMMATORY STEROIDS [PDF]

, 1978
Geoffrey J. Blackwell, R.J. Flower, Frans P. Nijkamp, John R. Vane   +3 more
openalex   +1 more source

Listeria phospholipases subvert host autophagic defenses by stalling pre‐autophagosomal structures

EMBO Journal, 2013
I. Tattoli, M. Sorbara, Chloe Yang, S. Tooze, D. Philpott, S. Girardin   +5 more
semanticscholar   +1 more source

Nanoparticle‐Based Tetracycline Delivery Systems: Advancing Therapeutic Effectiveness and Tackling Antibiotic Resistance

Particle &Particle Systems Characterization, EarlyView.
This review explores improved tetracycline (TCN) delivery via polymer‐based nanocarriers to enhance solubility, stability, and targeted release. It also covers stimuli‐responsive systems, triggered by pH, enzymes, or reactive oxygen species (ROS), and co‐delivery approaches that increase therapeutic efficacy in cancer and inflammatory diseases ...
Mahsa Molaei Nasr, Mehrab Pourmadadi, Fatemeh Yazdian, Hamid Rashedi, Abbas Rahdar, M. Ali Aboudzadeh   +5 more
wiley   +1 more source

Assessing the Utility of Broad-Acting Inhibitors as Therapeutics in Diverse Venoms. [PDF]

Toxins (Basel)
Kadler R, Morrison B, Yanagihara AA.
europepmc   +1 more source

EFFECT OF p‐BROMOPHENACYL BROMIDE, AN INHIBITOR OF PHOSPHOLIPASE A₂, ON ARACHIDONIC ACID RELEASE AND PROSTAGLANDIN SYNTHESIS BY THE GUINEA‐PIG UTERUS in vitro [PDF]

, 1977
Sheila M. Mitchell, N.L. Poyser, N.H. Wilson   +2 more
openalex   +1 more source

Effects of phospholipase A and pre-phospholipase A on black phospholipid membranes [PDF]

Biochimica et Biophysica Acta (BBA) - Biomembranes, 1968
Lesslauer, W., Slotboom, A.J., Postema, N.M., Haas, Gerard H. de, Deenen, L.L.M. van   +4 more
openaire   +4 more sources

An Up‐to‐Date Review of Traditional Chinese Medicine in the Treatment of Atherosclerosis: Components, Mechanisms, and Therapeutic Potentials

Phytotherapy Research, EarlyView.
Traditional Chinese medicine in atherosclerosis: multi‐target modulation of pathogenesis. ABSTRACT Atherosclerosis is a chronic inflammatory disease and a major global health concern. In recent years, traditional Chinese medicines (TCMs) have demonstrated multi‐target therapeutic potential against atherosclerosis by modulating inflammatory responses ...
Dilaram Nijat, Qingzhe Zhao, Gulhasal Abdurixit, Jianhua He, Haipeng Liu, Jinyao Li   +5 more
wiley   +1 more source

Secreted Phospholipases A2: Drivers of Inflammation and Cancer. [PDF]

Int J Mol Sci
Hidalgo I, Sorolla MA, Sorolla A, Salud A, Parisi E.   +4 more
europepmc   +1 more source